Cannara Biotech Delivers Record Fiscal 2025 Revenue and Profitability, Achieves First Year of Positive Retained Earnings
Record Fiscal 2025 Financial Performance: Record net revenues of $107.3 million, adjusted EBITDA of $28.1 million1, net income of $13.1 million, operating cash flow of $20 million and free cash flow of $13.7 million1 for Fiscal 2025. Stronger Balance Sheet an…
*Non-GAAP financial measure
CONTACT
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibilit…